advertisement
Abstract #19281 Published in IGR 9-3
Usefulness of a glaucoma and ocular hypertension screening strategy in primary care
Garcia De Blas Gonzalez F; Gutierrez MAB; Martin PB; Gonzalez MIDC; Cuesta TS; Cuadrado RV; Armendariz CSAtencion Primaria 2007; 39: 181-184
OBJECTIVES: To evaluate the usefulness of a glaucoma and intraocular hypertension screening strategy for new cases detected. To evaluate the acceptability of taking intraocular pressure (IOP) and the appearance of side effects. Design. Cross-sectional, descriptive study. Setting. An urban health centre and the ophthalmology clinic of its main hospital. PARTICIPANTS: A total of 2044 patients aged over 40, 63.5% women and 36.5% men, with a mean age of 61.23 (SD, 11.42). They were selected by consecutive sampling from patients who visited the health centre over a 9-month period. Subjects diagnosed with glaucoma, ocular hypertension (OH), conjunctivitis, or corneal pathology were excluded. Interventions. Taking of IOP with Tonopen XL in primary care. Subjects with IOP ≥ 21 mmHg were referred to ophthalmology. In these patients, IOP was measured with Goldmann, and patients with confirmed OH received ophthalmoscopy and campimetry. MAIN MEASUREMENTS: Percentage of subjects with glaucoma, suspected glaucoma, and OH confirmed in ophthalmology. Positive predictive value (PPV) for OH. RESULTS: One hundred subjects with OH were detected (4.89%; 95% CI, 3.93%-5.85%), of whom 21 were diagnosed with glaucoma (1.04%; 95% CI, 0.57-1.49) and 10 with suspected glaucoma (0.49%; 95% CI, 0.16-0.82). The PPV for OH was 44.27%. The acceptability of the test was 98.09%. No patients presented with side-effects following the taking of their IOP. CONCLUSIONS: The strategy evaluated is useful in terms of the number of subjects with glaucoma and OH detected. The acceptability of taking IOP with Tonopen XL was high. LA: Spanish
Dr. F. Garcia De Blas Gonzalez, Medicina Familiar Y Comunitaria Equipo de Atencion Primaria Dr. Mendiguchia Carriche. Leganes, Servicio Madrileno de Salud, Area 9, Madrid, Spain. fgarciadeblas@medynet.com
Classification:
1.6 Prevention and screening (Part of: 1 General aspects)
